Related Experiment Videos
Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin
1College of Pharmacy, University of Cincinnati, OH 45267-0004, USA.
Abstract:
The 3,4-methylenedioxymethamphetamine (MDMA)-induced increase in the extracellular concentration of dopamine and the long-term depletion of 5-HT were studied in the hippocampus of the rat brain. MDMA produced a dose-dependent increase in the extracellular concentration of dopamine in the hippocampus, as well as in the striatum. The MDMA-induced increase in the extracellular concentration of dopamine in the hippocampus, but not in the striatum, was suppressed in rats treated with the norepinephrine uptake inhibitor, desipramine, and in rats in which noradrenergic neurons in the hippocampus were lesioned with DSP4 (N-(2- chloroethyl)-N-ethyl-2-bromo benzylamine). However, the long-term depletion of 5-HT in the hippocampus produced by MDMA was unaltered in desipramine-treated rats. These results are supportive of the view that the MDMA-induced increase in the extracellular concentration of dopamine in the hippocampus is the result of an enhanced release of dopamine from noradrenergic neurons. In addition, the MDMA-induced depletion of 5-HT in the hippocampus appears not to involve dopamine-initiated processes, because suppression of MDMA-induced dopamine release did not attenuate the long-term depletion of 5-HT in the hippocampus.
Insights
3,4-methylenedioxymethamphetamine (MDMA) increases dopamine in the rat hippocampus via noradrenergic neurons. This MDMA effect on dopamine does not influence long-term serotonin depletion in the hippocampus.
Area of Science:
- Neuroscience
- Pharmacology
- Neurochemistry
Background:
- 3,4-methylenedioxymethamphetamine (MDMA) is known to affect neurotransmitter systems.
- The hippocampus is a brain region crucial for memory and is affected by MDMA.
- Understanding MDMA's neurochemical effects is vital for its clinical and toxicological assessment.
Purpose of the Study:
- To investigate the source of MDMA-induced dopamine release in the rat hippocampus.
- To determine the relationship between MDMA's effects on dopamine and serotonin in the hippocampus.
- To elucidate the role of noradrenergic pathways in MDMA's neurochemical actions.
Main Methods:
- Rats were administered varying doses of MDMA.
- Extracellular dopamine concentrations in the hippocampus and striatum were measured.
- Neurotransmitter levels were assessed following treatment with desipramine (norepinephrine uptake inhibitor) or DSP4 (noradrenergic neurotoxin).
Main Results:
- MDMA caused a dose-dependent increase in hippocampal and striatal dopamine.
- The increase in hippocampal dopamine was attenuated by desipramine and DSP4, but striatal dopamine was not affected.
- Long-term serotonin depletion in the hippocampus by MDMA was not altered by desipramine treatment.
Conclusions:
- MDMA-induced dopamine release in the hippocampus originates from noradrenergic neurons.
- MDMA's long-term serotonin depletion in the hippocampus is independent of dopamine release.
- These findings clarify the specific mechanisms underlying MDMA's neurochemical effects in the hippocampus.